"We think we’re going to have major breakthroughs in the next few years to better treat the symptoms and try to slow the ...

According to a study published in the international journal, the number of Parkinson's disease patients worldwide is expected ...

Parkinson’s disease is a debilitating neurodegenerative disorder that affects approximately 1.1 million Americans. It is ...

It was the early 2000s when researchers first showed that exercise can help relieve the tremors that are common with ...

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the ...

Dr. Melinda Cail from Primary Health Partners joins us in the KFOR Studios on Thursday afternoon to discuss Parkinson's disease.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford scientists reporting improvement in neuron communication in mice.

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...

Parkinson's Disease Therapeutics Market The Parkinson's therapeutics market will grow from USD 5.92 Bn in 2024 to USD 12.83 Bn by 2033 at 8 ...

UniSA's weekly injectable gel delivers levodopa and carbidopa, potentially transforming Parkinson's care for 8.5M people by simplifying treatment and reducing side effects.

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering a potential inexpensive screening tool.